• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2021; 45(1) e1-e3

Published on-line:

November 24, 2020

DOI:

10.19186/BC_2020.060

Download in PDF:

Il valore aggiunto della diagnostica molecolare nelle forme monogeniche di diabete mellito
Advantages of molecular diagnosis in monogenic diabetes

AUTHORS

Fernanda Iafusco1,2, Serena Meola1,2, Barbara Lombardo1,2, Antonella Gambale2, Antonio Alderisio3, Salvatore Genovese3, Achille Iolascon1,2, Lucio Pastore1,2, Nadia Tinto1,2
1Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Federico II, Napoli
2CEINGE Biotecnologie Avanzate Scarl
2Unità di Diabetologia - D.A.I. di Medicina Clinica AOU Federico II, Napoli

ABSTRACT

Advantages of molecular diagnosis in monogenic diabetes

Maturity Onset Diabetes of the Young (MODY), the most frequent form of monogenic diabetes, comprises a group of heterogeneous disorders, characterized by non-autoimmune diabetes due to mutations of at least 14 different genes.
We report a case of a 38-years-old patient with non-autoimmune diabetes, where molecular analysis evidenced a large deletion on chromosome 17q12 including several genes, among them HNF1β associated to MODY5. The analysis allowed us to clarify the complex phenotype of the patient including, in addition to diabetes, intellectual disability, seizures, kidney cysts and facial dimorphisms. This case shows that diabetes when caused by large deletions, can be just one of the symptoms of a “clinical syndrome” that includes other features due to the deletion of neighboring genes and confirms the important role of the molecular test to obtain a correct diagnosis in a patient with a suspicion of monogenic diabetes.

REFERENCES